Skip to main content
Top
Published in: Acta Diabetologica 5/2019

01-05-2019 | Prediabetes | Original Article

Prediabetes defined by the International Expert Committee as a risk for development of glomerular hyperfiltration

Authors: Iori Kawata, Tomomichi Koshi, Kazuko Hirabayashi, Hideo Koike, Yuka Sato, Koh Yamashita, Tomomasa Oguchi, Toru Aizawa

Published in: Acta Diabetologica | Issue 5/2019

Login to get access

Abstract

Aims

To clarify if prediabetes defined by the International Expert Committee (PrediabetesIEC) and/or the American Diabetes Society (PrediabetesADA) is a risk for incident glomerular hyperfiltration (GH).

Methods

24,524 health examinees without diabetes, chronic kidney disease (CKD), GH and antihypertensive treatment at baseline, and repeated examinations at least twice during a mean of 5.3 years were retrospectively analysed. Diabetes was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or HbA1c ≥ 47 mmol/mol, CKD by estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2 and/or dipstick-positive proteinuria, and GH by upper 95th eGFR in the Japanese adults. PrediabetesIEC was diagnosed by “HbA1c 42–46 mmol/mol and/or FPG 6.1–6.9 mmol/L”, PrediabetesADA by “HbA1c 39–46 mmol/mol and/or FPG 5.6–6.9 mmol/L”, PrediabetesADA−IEC for the condition met the ADA but not the IEC prediabetes definition, and the ADA-normal glucose regulation (NGRADA) by both HbA1c and FPG lower than PrediabetesADA. Risk of PrediabetesIEC and PrediabetesADA for incident GH was examined by multivariate Cox proportional hazards model with seven covariates and probability of incident GH was calculated on the basis of it.

Results

PrediabetesIEC was a significant risk for incident GH [adjusted HR 1.91, 95% CI 1.32–2.71] but PrediabetesADA was not [adjusted HR 1.22, 95% CI 0.93–1.61]. The mean (SD) probability of incident GH was 2.3 (4.5)%, 1.0 (2.3)% and 1.0 (2.4)% for PrediabetesIEC, PrediabetesADA−IEC and NGRADA, respectively: the former was significantly larger than the latter two which were not significantly different from each other.

Conclusions

PrediabetesIEC was an independent risk for incident GH.
Literature
1.
go back to reference Christiansen JS (1985) Glomerular hyperfiltration in diabetes mellitus. Diabet Med 2:235–239CrossRef Christiansen JS (1985) Glomerular hyperfiltration in diabetes mellitus. Diabet Med 2:235–239CrossRef
2.
go back to reference Sun ZJ, Yang YC, Wu JS, Wang MC, Chang CJ, Lu FH (2016) Increased risk of glomerular hyperfiltration in subjects with impaired glucose tolerance and newly diagnosed diabetes. Nephrol Dial Transpl 31:1295–1301CrossRef Sun ZJ, Yang YC, Wu JS, Wang MC, Chang CJ, Lu FH (2016) Increased risk of glomerular hyperfiltration in subjects with impaired glucose tolerance and newly diagnosed diabetes. Nephrol Dial Transpl 31:1295–1301CrossRef
3.
go back to reference Rodriguez-Poncelas A, Coll-de-Tuero G, Blanch J, Comas-Cufí M, Saez M, Barceló MA (2018) Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study. J Nephrol 31:743–749CrossRef Rodriguez-Poncelas A, Coll-de-Tuero G, Blanch J, Comas-Cufí M, Saez M, Barceló MA (2018) Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study. J Nephrol 31:743–749CrossRef
4.
go back to reference Melsom T, Schei J, Stefansson VT et al (2016) Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study. Am J Kidney Dis 67:841–850CrossRef Melsom T, Schei J, Stefansson VT et al (2016) Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study. Am J Kidney Dis 67:841–850CrossRef
5.
go back to reference Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S (2012) Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transpl 27:1821–1825CrossRef Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S (2012) Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transpl 27:1821–1825CrossRef
6.
go back to reference Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691–697CrossRef Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691–697CrossRef
7.
go back to reference Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ (2015) Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol 26:1426–1433CrossRef Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ (2015) Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol 26:1426–1433CrossRef
8.
go back to reference International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef
9.
go back to reference American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37:S81–S90CrossRef American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37:S81–S90CrossRef
10.
go back to reference Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713–735CrossRef Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713–735CrossRef
11.
go back to reference Matsuo S, Imai E, Horio M et al (2009) Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef Matsuo S, Imai E, Horio M et al (2009) Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef
12.
go back to reference Paulmichl K, Hatunic M, Højlund K et al (2016) Beta-JUDO Investigators; RISC Investigators. Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: the single point insulin sensitivity estimator (SPISE). Clin Chem 62:1211–1219CrossRef Paulmichl K, Hatunic M, Højlund K et al (2016) Beta-JUDO Investigators; RISC Investigators. Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: the single point insulin sensitivity estimator (SPISE). Clin Chem 62:1211–1219CrossRef
13.
go back to reference Sagesaka H, Sato Y, Someya Y et al (2018) Type 2 diabetes: when does it start? J Endocr Soc 2:476–484CrossRef Sagesaka H, Sato Y, Someya Y et al (2018) Type 2 diabetes: when does it start? J Endocr Soc 2:476–484CrossRef
14.
go back to reference Hirakawa Y, Ninomiya T, Mukai N et al (2012) Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. Am J Epidemiol 176:856–864CrossRef Hirakawa Y, Ninomiya T, Mukai N et al (2012) Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. Am J Epidemiol 176:856–864CrossRef
15.
go back to reference Hanefeld M, Sulk S, Helbig M, Thomas A, Köhler C (2014) Differences in glycemic variability between normoglycemic and prediabetic subjects. J Diabetes Sci Technol 8:286–290CrossRef Hanefeld M, Sulk S, Helbig M, Thomas A, Köhler C (2014) Differences in glycemic variability between normoglycemic and prediabetic subjects. J Diabetes Sci Technol 8:286–290CrossRef
Metadata
Title
Prediabetes defined by the International Expert Committee as a risk for development of glomerular hyperfiltration
Authors
Iori Kawata
Tomomichi Koshi
Kazuko Hirabayashi
Hideo Koike
Yuka Sato
Koh Yamashita
Tomomasa Oguchi
Toru Aizawa
Publication date
01-05-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01287-9

Other articles of this Issue 5/2019

Acta Diabetologica 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.